Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab
Clinical trial NCT02338245 · COMPLETED
Trial details
- NCT number
- NCT02338245
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-29
- Primary completion
- 2016-05-19
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.